a small trendgold
PD-1 −/− HSC recipients at the peak of disease (day 45) demonstrated no significant difference in splenic CD4 or CD8 T cell populations although a small trend toward increased expression in PD-1 −/− HSC recipient CD8 T cells was noted (Figure S2 in Supplementary Material).